BNP/PUT/AMGEN/250/0.1/17.01.25 | Market Closed - Deutsche Boerse AG 03:50:24 2024-07-05 pm EDT | ||
| 0.52 EUR | -1.89% |
|
| Current month | +6.12% | ||
| 1 month | -26.76% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 0.52 | -1.89% |
| 24-07-04 | 0.53 | +3.92% |
| 24-07-03 | 0.51 | 0.00% |
| 24-07-02 | 0.51 | -1.92% |
| 24-07-01 | 0.52 | +6.12% |
Delayed Quote Deutsche Boerse AG
Last update July 05, 2024 at 03:50 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
BNP Paribas
|
| WKN | PN6Z75 |
| ISIN | DE000PN6Z753 |
| Date issued | 2023-08-11 |
| Strike | 250 $ |
| Maturity | 2025-01-17 (195 Days) |
| Parity | 10 : 1 |
| Emission price | 1.71 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.49 € |
|---|---|
| Lowest since issue | 0.39 € |
| Spread | 0.02 € |
| Spread % | 3.70% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.9
USD
Average target price
316.4
USD
Spread / Average Target
+1.79%
- Stock Market
- Warrants
- Warrant
